Way Towards New Life

Genetic Drugs

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Get access to an unapproved drug for personal use.

Here is a list of some of the  Genetic Medicines for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

ZOLGENSMA (onasemnogene abeparvovec-xioi) suspension

Zolgensma is a gene therapy medicine for treating spinal muscular atrophy, a serious condition of the nerves that causes muscle wasting and weakness.

WELIREG (belzutifan) Tablets

WELIREG is a prescription medicine used to treat adults with von Hippel-Lindau (VHL) disease who need treatment for a type of kidney cancer called renal cell carcinoma (RCC),

VIMIZIM (elosulfase alfa) injection

Vimizim is used to treat some of the symptoms of a genetic condition called mucopolysaccharidosis IV (4) type A, or MPS IV A, also called Morquio A syndrome.

SPINRAZA (nusinersen) injection

SPINRAZA® (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.

SKYCLARYS (omaveloxolone) capsules, for oral use

SKYCLARYS is used for the treatment of Friedreich ataxia in adults and children 16 years of age and older.

ELAPRASE (idursulfase) Solution

Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter’s syndrome, also called mucopolysaccharidosis .

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.






Hepatitis C

Hematologic Cancers


Immunological Disorders

Liver Disease

Multiple Sclerosis

Nerver Disease


Parkinson's Disease

Rare Disease

Soft Tissue Sarcoma


Specialty Drugs

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha


All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.